An Introduction to PEPAXTO: The First Anticancer Peptide-Drug Conjugate...

Jun 24, 2021 12:00pm -
Jun 24, 2021 02:00pm
Virtual

Event Description

An Introduction to PEPAXTO: The First Anticancer Peptide-Drug Conjugate for the Management of Multiple Myeloma in Patients Who Have Received at Least 4 Prior Lines and are Triple-Class Refractory
 

Presenter:  TBA

Date: Thursday June 24, 2021 
Time: 12:00 PM ET; 9:00 AM PT

 

IMPORTANT: There is a 2 step registration process -
After registering on this site, you will receive a confirmation email with instructions to register with GoToWebinar to receive your logon instructions and calendar reminder.

This webinar is sponsored by:

PharmaBoardroom | Oncopeptides


Event Type:Webinar
Category:Webinar
Early registration ends on Apr 03, 2021.
Regular registration starts on Apr 04, 2021 and ends on Jun 23, 2021.
Late registration starts on Jun 24, 2021.